Monthly Archives: March, 2011
A new start looking at ethics in overseas clinical trials
In the public meeting today on the ethics around human subjects in clinical trials overseas, members of the Presidential Commission for the Study of Bioethical Issues were looking for both perspective and ideas on how to move ahead. Dan W. Brock, the Frances Glessner Lee Professor of Medical Ethics, and Director of the Division of [...]
The overseas migration of clinical trials
So what are the trends on overseas human subject trials? An important one is that more and more clinical trials are being done outside the United States. Dr. Robert M. Califf, Vice Chancellor for Clinical Research at Duke University, told the Presidential Commission for the Study of Bioethical Issues, that a “massive shift” has occurred [...]
Spending days in the archives, hunting for clues
While an International Research Panel will soon start its review of ongoing scientific trials using human subjects, a separate review already is well under way: A focus on what happened in the Guatemala trials in which U.S.-sponsored research deliberately injected hundreds of people with a sexually transmitted disease from 1946 to 1948. Valerie H. Bonham, [...]
International panel named to review scientific trials
Kicking off a five-month study of the ethics around contemporary human subjects clinical trials, the Presidential Commission for the Study of Bioethical Issues today named an International Research Panel to study the issue. The international panel consists of 14 members, of which 10 are from outside the United States. The announcement follows a request by [...]
